SCHEMBL31064441

SCHEMBL31064441

CC(NC1CCC1)c1ncc(C2CC2)cc1F

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 1/20 0.39
S1PR3 Q99500 1/20 0.39
GPR55 Q9Y2T6 1/20 0.37
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
DHODH Q02127 3/20 0.34
ADRB3 P13945 1/20 0.34
ADRA1D P25100 1/20 0.34
SLC6A4 P31645 1/20 0.34
ABAT P80404 1/20 0.34
TMEM97 Q5BJF2 1/20 0.34
ROCK2 O75116 2/20 0.31
PRKG1 Q13976 2/20 0.31
MAPK1 P28482 1/20 0.31
PDGFRB P09619 1/20 0.31
PDGFRA P16234 1/20 0.31
CNR1 P21554 1/20 0.31
CNR2 P34972 1/20 0.31
ACACB O00763 4/20 0.30
JAK2 O60674 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31064451 0.82 S1PR1 (0.42) S1PR1S1PR3GPR55DHODHADRB3
Hydrochloric Acid SCHEMBL31064255 0.81 S1PR1 (0.41) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL21139636 0.80 S1PR1 (0.44) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL31064333 0.80 GAA (0.44) GAAL3MBTL1MAPK1ACACB
Hydrochloric Acid SCHEMBL31064700 0.78 S1PR1 (0.39) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL31064639 0.76 S1PR1 (0.41) S1PR1S1PR3GPR55DHODHADRB3
SCHEMBL31613953 0.73 GAA (0.49) GPR55GAAMAPK1ACACB
SCHEMBL31064628 0.72 L3MBTL1 (0.41) S1PR1S1PR3GPR55GAAL3MBTL1
SCHEMBL31187846 0.71 ACACB (0.41) S1PR3ROCK2PRKG1ACACB
SCHEMBL31064345 0.69 TRPV3 (0.36) S1PR1S1PR3GPR55DHODHADRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4688785-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-D] PYRROLO [3, 2-B] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 Beone Medicines I GmbH (CH) 2026-02-11 EP disclosed
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-11-07 US disclosed
WO-2024199255-A1 5-AMINO-6, 8-DIHYDRO-1H-FURO [3, 4-d] PYRROLO [3, 2-b] PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 BEIGENE SWITZERLAND GMBH (CH) 2024-10-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240368177-A1 5-AMINO-6,8-DIHYDRO-1H-FURO[3,4-d]PYRROLO[3,2-b]PYRIDINE-2-CARBOXAMIDE DERIVATIVES AS MTA-COOPERATIVE INHIBITORS OF PRMT5 PRMT5, PRMT6, PRMT1 S1PR1 3736/4885S1PR3 3423/4885GPR55 1766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.